Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir.
Basic Information
ID: ALA2010769
Journal: Bioorg Med Chem
Title: Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir.
Authors: Li C, Quenelle DC, Prichard MN, Drach JC, Zemlicka J.
Abstract: Synthesis of 6-deoxycyclopropavir (10), a prodrug of cyclopropavir (1) and its in vitro and in vivo antiviral activity is described. 2-Amino-6-chloropurine methylenecyclopropane 13 was transformed to its 6-iodo derivative 14 which was reduced to prodrug 10. It is converted to cyclopropavir (1) by the action of xanthine oxidase and this reaction can also occur in vivo. Compound 10 lacked significant in vitro activity against human cytomegalovirus (HCMV), human herpes virus 1 and 2 (HSV-1 and HSV-2), human immunodeficiency virus type 1 (HIV-1), human hepatitis B virus (HBV), Epstein-Barr virus (EBV), vaccinia virus and cowpox virus. In contrast, prodrug 10 given orally was as active as cyclopropavir (1) reported previously [Kern, E. R.; Bidanset, D. J.; Hartline, C. B.; Yan, Z.; Zemlicka, J.; Quenelle, D. C. et al. Antimicrob. Agents Chemother. 2004, 48, 4745] against murine cytomegalovirus (MCMV) infection in mice and against HCMV in severe combined immunodeficient (SCID) mice.
CiteXplore: 22417649
DOI: 10.1016/j.bmc.2012.02.031
Patent ID: ┄